Management of hemopoietic neoplasias during pregnancy

PAYDAŞ S.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol.104, pp.52-64, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 104
  • Publication Date: 2016
  • Doi Number: 10.1016/j.critrevonc.2016.05.006
  • Journal Name: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.52-64
  • Keywords: Hemopoietic neoplasia, Pregnancy, Chemotherapy, Radiation therapy, Supportive care, Leukemia, Lymphoma, Myeloproliferative neoplasia, Fertility preservation, CHRONIC MYELOID-LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, NON-HODGKINS-LYMPHOMA, ESSENTIAL THROMBOCYTHEMIA, MULTIPLE-MYELOMA, INTERFERON-ALPHA, HEMATOLOGICAL MALIGNANCIES, CHEMOTHERAPEUTIC-AGENTS, ANTINEOPLASTIC AGENTS, INDUCTION THERAPY
  • Çukurova University Affiliated: Yes

Abstract

Hemopoietic neoplasias are unique cancers generally affecting bone marrow, and requires a special attention for disease control and also their complications. When these neoplastic disorders accompany to pregnancy there are many risks both for mother and foetus. Diagnostic difficulties due to the limited use of imaging modalities is essential in pregnant women. On the other hand suboptimal using of the antineoplastic drugs and their higher toxicity in mother and foetus must be considered in the management of these neoplastic disorders. Due to the lack of therapeutic guidelines in these cases, team approach is essential and therapy requires to the use the art of medicine. (C) 2016 Elsevier Ireland Ltd. All rights reserved.